← brief for 2026-10-15 · Slowing decline

GLP-1 receptor agonists as novel renoprotective agents in lupus nephritis

Article D Peer reviewed Preclinical

Key takeaways

A diabetes drug called liraglutide may protect kidneys in mice with lupus. The study used mice that are prone to developing lupus and kidney damage. It showed the drug helped reduce kidney injury in these animals. This is early research in mice, not people, but it suggests the drug could help humans with lupus-related kidney disease.

Who did this work

Xinyu Zhao (Zhengzhou University) · Chen Liu (Zhengzhou University) · Yongchun Li (Zhengzhou University) · Junpeng You (Zhengzhou University) · Yu-hui Gan (Zhengzhou University) · Huimiao Hu (Zhengzhou University) · Li Shuangshuang (Zhengzhou University) · Weijing Yong (Zhengzhou University) · Xiaoyang Wang (Zhengzhou University) · Xiaoxue Zhang (Zhengzhou University) · Yaling Zhai (Zhengzhou University) · Genyang Cheng (Zhengzhou University)

Source

Article · OpenAlex, CKD works · 2026-10-14
https://doi.org/10.1186/s13075-026-03922-7